121 related articles for article (PubMed ID: 37691152)
1. Preliminary PET imaging of [
Boyle AJ; Lindberg A; Tong J; Zhai D; Liu F; Vasdev N
J Labelled Comp Radiopharm; 2024 May; 67(6):235-244. PubMed ID: 37691152
[TBL] [Abstract][Full Text] [Related]
2. Radiosynthesis of a Bruton's tyrosine kinase inhibitor, [
Dahl K; Turner T; Vasdev N
J Labelled Comp Radiopharm; 2020 Sep; 63(11):482-487. PubMed ID: 32726870
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
Bar-Or A; Cross AH; Cunningham AL; Hyvert Y; Seitzinger A; Gühring H; Drouin EE; Alexandri N; Tomic D; Montalban X
Mult Scler; 2023 Oct; 29(11-12):1471-1481. PubMed ID: 37626477
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and Preliminary Evaluation of [
Li KP; Gleba JJ; Parent EE; Knight JA; Copland JA; Cai H
Mol Pharm; 2023 Aug; 20(8):4129-4137. PubMed ID: 37409698
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
Haselmayer P; Camps M; Liu-Bujalski L; Nguyen N; Morandi F; Head J; O'Mahony A; Zimmerli SC; Bruns L; Bender AT; Schroeder P; Grenningloh R
J Immunol; 2019 May; 202(10):2888-2906. PubMed ID: 30988116
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain.
Yu Y; Jiang H; Liang Q; Qiu L; Huang T; Hu H; Bolshakov VY; Perlmutter JS; Tu Z
Mol Imaging Biol; 2023 Apr; 25(2):334-342. PubMed ID: 35951211
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1.
Huang T; Gu J; Jiang H; Liang Q; Perlmutter JS; Tu Z
Nucl Med Biol; 2022; 110-111():18-27. PubMed ID: 35472678
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [
Xu Z; Jia L; Liu W; Li W; Song Y; Zheng QH
Appl Radiat Isot; 2020 Aug; 162():109190. PubMed ID: 32501230
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
13.
Ruiz-Bedoya CA; Mota F; Ordonez AA; Foss CA; Singh AK; Praharaj M; Mahmud FJ; Ghayoor A; Flavahan K; De Jesus P; Bahr M; Dhakal S; Zhou R; Solis CV; Mulka KR; Bishai WR; Pekosz A; Mankowski JL; Villano J; Klein SL; Jain SK
Mol Imaging Biol; 2022 Feb; 24(1):135-143. PubMed ID: 34424479
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
15. Automated two-step manufacturing of [
Caillé F; Gervais P; Auvity S; Coulon C; Marie S; Tournier N; Kuhnast B
Nucl Med Biol; 2020; 84-85():20-27. PubMed ID: 31931306
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of
Roslin S; Brandt P; Nordeman P; Larhed M; Odell LR; Eriksson J
Molecules; 2017 Oct; 22(10):. PubMed ID: 28994734
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of [
Estrada S; Elgland M; Selvaraju RK; Mani K; Tegler G; Wanhainen A; Wågsäter D; Bergström M; Jimenez-Royo P; Jahan M; Nordeman P; Antoni G
Nucl Med Biol; 2022; 106-107():62-71. PubMed ID: 35066391
[TBL] [Abstract][Full Text] [Related]
18. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
19. Efficient 11C-carbonylation of isolated aryl palladium complexes for PET: application to challenging radiopharmaceutical synthesis.
Andersen TL; Friis SD; Audrain H; Nordeman P; Antoni G; Skrydstrup T
J Am Chem Soc; 2015 Feb; 137(4):1548-55. PubMed ID: 25569730
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.
Dong F; Du J; Miao C; Jia L; Li W; Wang M; Zheng QH; Xu Z
Appl Radiat Isot; 2019 Dec; 154():108873. PubMed ID: 31470193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
